AtifShafqatMD

Oncology • Saint Louis, MO

Breast Cancer, Genitourinary Oncology, Hematologic Oncology

Chief of Oncology Division, Chair Cancer Committee, President and Co-director Oncology Program.

Join to view full profile

Dr. Shafqat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Shafqat's full profile

Already have an account?

Office
3015 N Ballas Rd
Saint Louis, MO 63131
Phone+1 314-996-5514

Fax+1 314-996-5674
Is this information wrong?

Summary

Board certified in hematology and oncology. Specializes in Breast cancer, Testicular Cancer plus benign and malignant Hematology. Active participant in NCORP research program.

Education & Training

Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2005
Duke University HospitalResidency, Internal Medicine, 1995 - 1998
Aga Khan Medical CollegeClass of 1993

Certifications & Licensure

MO State Medical License 2005 - 2025
NC State Medical License 1998 - 2003
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Hematology
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Fellow (FACP) American College of Physicians, 2007

Publications & Presentations

PubMed

A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS): Results from ECOG-ACRIN E1Z11.
Vered Stearns, Opeyemi A Jegede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilm...> ;Clinical Cancer Research. 2024 Apr 19
106 citations
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial
Heather A. Wakelee, Suzanne E. Dahlberg, Steven M. Keller, William Tester, David R. Gandara, Stephen L. Graziano, Alex A. Adjei, Natasha B. Leighl, Seena C. Aisner, Ja...> ;The Lancet. Oncology. 2017 Dec 1
A phase II study of venlafaxine for the treatment of hot flashes in men undergoing androgen deprivation for prostate cancer.
Shafqat A, Titzer ML, Sweeney CJ, Giesler RB, Hanna A, Porter J, Selbe K, Daggy J, Einhorn LH> ;J. Clin. Oncol.. 2004-07-15
6 citations
Unusual locations of involvement by malignancies: Case 1. Testicular plasmacytoma.
Atif Shafqat, Moonahm Yum, Rafat Abanour, Kristen N. Ganjoo> ;Journal of Clinical Oncology. 2003 Sep 1
17 citations
Cutaneous squamous cell carcinoma with zosteriform metastasis in a transplant recipient.
Atif Shafqat, Greg E. Viehman, Sarah A. Myers> ;Journal of the American Academy of Dermatology. 1997 Dec 1
Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment.
Shafqat, A., Einhorn, L. H., Hanna, N., Sledge, G. W., Hanna, A., Juliar, B. E., Monahan, P., Bhatia, S.> ;Ann Oncol. 2005 Sep
Clinico-pathological features and survival of patients presenting with hepatic metastases: a retrospective analysis.
Shafqat, A., Merchant, M., Malik, I. A.> ;J Pak Med Assoc. 1996 May
Join now to see all

Professional Memberships

American College of Physicians - ACP
Fellow

Hospital Affiliations

Ste. Genevieve County Memorial HospitalSte. Genevieve, Missouri
Barnes-Jewish West County HospitalSaint Louis, Missouri